New Monthly GLP-1 Injectable MariTide Results in 20% Weight Loss—With No Plateau
In the same way weight varies from person to person, so do the best weight loss strategies. While some people succeed with diet and exercise alone, others find that adding weight loss medications like Wegovy or Zepbound helps them stay on track with their goals. Now, biopharmaceutical company Amgen has been developing a new weight loss drug called MariTide—and early trials are showing big results.
Dr. Evan provides expert insight on MariTide’s unique mechanism and clinical potential, sharing key quotes that shed light on how this once-monthly GLP‑1 and GIP-receptor agonist could revolutionize weight management.
Read the full article here to learn about the new GLP-1 receptor agonist that could rival Ozempic.
